Literature DB >> 17961113

Platelet count is associated with plasma HIV type 1 RNA and disease progression.

Gunter Rieg1, Michael Yeaman, Alice E Lail, Sharyne M Donfield, Edward D Gomperts, Eric S Daar.   

Abstract

Thrombocytopenia is a common finding among HIV-1-infected individuals. In addition to their function in hemostasis, platelets have been found to play a role in host immune defenses and to directly interact with HIV-1. To explore the role of platelets in HIV-1 infection, we examined the relationship between platelet number and the natural history of HIV-1 disease in the well-characterized Hemophilia Growth and Development Study cohort. In a multivariate analysis platelets were found to be inversely related to plasma HIV-1 RNA with increasing platelets associated with lower plasma HIV-1 RNA levels (p < 0.001). Despite this, increasing platelet count was independently associated with enhanced risk of progression to AIDS and death (p < 0.001 for both). While there may be multiple explanations for these novel observations, they do generate hypotheses related to the potential influence platelets may have on the natural history of HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961113     DOI: 10.1089/aid.2006.0311

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  15 in total

Review 1.  Platelets: at the nexus of antimicrobial defence.

Authors:  Michael R Yeaman
Journal:  Nat Rev Microbiol       Date:  2014-06       Impact factor: 60.633

2.  Platelet leukocyte aggregates and markers of platelet aggregation, immune activation and disease progression in HIV infected treatment naive asymptomatic individuals.

Authors:  Bongani B Nkambule; Glenda Davison; Hayley Ipp
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

3.  Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection.

Authors:  Martin Hoenigl; Dominique L Braun; Roger Kouyos; Huldrych F Günthard; Susan J Little
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-01       Impact factor: 3.731

4.  Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.

Authors:  Kristen M Marks; Robin M A Clarke; James B Bussel; Andrew H Talal; Marshall J Glesby
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

5.  HIV and SIV Associated Thrombocytopenia: An Expanding Role for Platelets in the Pathogenesis of HIV.

Authors:  Kelly A Metcalf Pate; Joseph L Mankowski
Journal:  Drug Discov Today Dis Mech       Date:  2011-11-09

6.  Characterization of a new simian immunodeficiency virus strain in a naturally infected Pan troglodytes troglodytes chimpanzee with AIDS related symptoms.

Authors:  Lucie Etienne; Eric Nerrienet; Matthew LeBreton; Godwin Tafon Bibila; Yacouba Foupouapouognigni; Dominique Rousset; Ahmadou Nana; Cyrille F Djoko; Ubald Tamoufe; Avelin F Aghokeng; Eitel Mpoudi-Ngole; Eric Delaporte; Martine Peeters; Nathan D Wolfe; Ahidjo Ayouba
Journal:  Retrovirology       Date:  2011-01-13       Impact factor: 4.602

7.  Platelets kill circulating parasites of all major Plasmodium species in human malaria.

Authors:  Steven Kho; Bridget E Barber; Edison Johar; Benediktus Andries; Jeanne R Poespoprodjo; Enny Kenangalem; Kim A Piera; Anna Ehmann; Ric N Price; Timothy William; Tonia Woodberry; Simon Foote; Gabriela Minigo; Tsin W Yeo; Matthew J Grigg; Nicholas M Anstey; Brendan J McMorran
Journal:  Blood       Date:  2018-07-19       Impact factor: 25.476

8.  Platelet activation suppresses HIV-1 infection of T cells.

Authors:  Theodros Solomon Tsegaye; Kerstin Gnirß; Niels Rahe-Meyer; Miriam Kiene; Annika Krämer-Kühl; Georg Behrens; Jan Münch; Stefan Pöhlmann
Journal:  Retrovirology       Date:  2013-05-01       Impact factor: 4.602

9.  Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders.

Authors:  Donna C Davidson; Michael P Hirschman; Anita Sun; Meera V Singh; Karl Kasischke; Sanjay B Maggirwar
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

10.  Hiding in plain sight - platelets, the silent carriers of HIV-1.

Authors:  Yvonne Baumer; Tina M Weatherby; Brooks I Mitchell; Ivo N SahBandar; Thomas A Premeaux; D'Antoni Michelle L; Cristhian A Gutierrez-Huerta; Tiffany M Powell-Wiley; Timothy R Brown; William A Boisvert; Cecilia M Shikuma; Lishomwa C Ndhlovu
Journal:  Platelets       Date:  2020-11-23       Impact factor: 4.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.